Characterization of the Epidermal Growth Factor Receptor T790M Mutation in Colorectal Cancer

被引:2
作者
Altunel, Erdem [1 ,2 ]
Aljamal, Abed Alhalim [1 ,2 ]
Mantyh, John [1 ]
Deak, Kristen [2 ]
Glover, Wayne [1 ,2 ]
Mccall, Shannon J. [2 ]
Datto, Michael [2 ]
Strickler, John [1 ]
Hsu, David S. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, 3008 Snyderman Bldg,905 S LaSalle St, Durham, NC 27710 USA
[2] Duke Univ, Durham, NC 27710 USA
关键词
D O I
10.1200/PO.18.00194
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 7
页数:7
相关论文
共 11 条
[1]   Third-Generation Tyrosine Kinase inhibitors Targeting epidermal Growth Factor Receptor Mutations in non-Small Cell Lung Cancer [J].
Barnes, Tristan A. ;
O'Kane, Grainne M. ;
Vincent, Mark David ;
Leighl, Natasha B. .
FRONTIERS IN ONCOLOGY, 2017, 7
[2]   AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer [J].
Cross, Darren A. E. ;
Ashton, Susan E. ;
Ghiorghiu, Serban ;
Eberlein, Cath ;
Nebhan, Caroline A. ;
Spitzler, Paula J. ;
Orme, Jonathon P. ;
Finlay, M. Raymond V. ;
Ward, Richard A. ;
Mellor, Martine J. ;
Hughes, Gareth ;
Rahi, Amar ;
Jacobs, Vivien N. ;
Brewer, Monica Red ;
Ichihara, Eiki ;
Sun, Jing ;
Jin, Hailing ;
Ballard, Peter ;
Al-Kadhimi, Katherine ;
Rowlinson, Rachel ;
Klinowska, Teresa ;
Richmond, Graham H. P. ;
Cantarini, Mireille ;
Kim, Dong-Wan ;
Ranson, Malcolm R. ;
Pao, William .
CANCER DISCOVERY, 2014, 4 (09) :1046-1061
[3]   Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib [J].
Ho, Chao-Chi ;
Liao, Wei-Yu ;
Lin, Chih-An ;
Shih, Jin-Yuan ;
Yu, Chong-Jen ;
Yang, James Chih-Hsin .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) :567-572
[4]   Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients [J].
Hu, Yuebi ;
Alden, Ryan S. ;
Odegaard, Justin I. ;
Fairclough, Stephen R. ;
Chen, Ruthia ;
Heng, Jennifer ;
Feeney, Nora ;
Nagy, Rebecca J. ;
Shah, Jayshree ;
Ulrich, Bryan ;
Gutierrez, Martin ;
Lanman, Richard B. ;
Garber, Judy E. ;
Paweletz, Cloud P. ;
Oxnard, Geoffrey R. .
CLINICAL CANCER RESEARCH, 2017, 23 (23) :7351-7359
[5]   Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer [J].
Kim, Mickey K. ;
Osada, Takuya ;
Barry, William T. ;
Yang, Xiao Yi ;
Freedman, Jennifer A. ;
Tsamis, Katherine A. ;
Datto, Michael ;
Clary, Bryan M. ;
Clay, Timothy ;
Morse, Michael A. ;
Febbo, Philip G. ;
Lyerly, H. Kim ;
Hsu, David S. .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (07) :1500-1509
[6]   Mechanisms of resistance to EGFR-targeted drugs: lung cancer [J].
Morgillo, Floriana ;
Della Corte, Carminia Maria ;
Fasano, Morena ;
Ciardiello, Fortunato .
ESMO OPEN, 2016, 1 (03)
[7]   FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation [J].
Odogwu, Lauretta ;
Mathieu, Luckson ;
Goldberg, Kirsten B. ;
Blumenthal, Gideon M. ;
Larkins, Erin ;
Fiero, Mallorie H. ;
Rodriguez, Lisa ;
Bijwaard, Karen ;
Lee, Eunice Y. ;
Philip, Reena ;
Fan, Ingrid ;
Donoghue, Martha ;
Keegan, Patricia ;
McKee, Amy ;
Pazdur, Richard .
ONCOLOGIST, 2018, 23 (03) :353-359
[8]   Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain [J].
Pao, W ;
Miller, VA ;
Politi, KA ;
Riely, GJ ;
Somwar, R ;
Zakowski, MF ;
Kris, MG ;
Varmus, H .
PLOS MEDICINE, 2005, 2 (03) :225-235
[9]   Epidermal growth factor receptor T790M mutation-positive metastatic non-small-cell lung cancer: focus on osimertinib (AZD9291) [J].
Saad, Nibal ;
Poudel, Aarati ;
Basnet, Alina ;
Gajra, Ajeet .
ONCOTARGETS AND THERAPY, 2017, 10 :1757-1765
[10]   Histological and Molecular Evaluation of Patient-Derived Colorectal Cancer Explants [J].
Uronis, Joshua M. ;
Osada, Takuya ;
McCall, Shannon ;
Yang, Xiao Yi ;
Mantyh, Christopher ;
Morse, Michael A. ;
Lyerly, H. Kim ;
Clary, Bryan M. ;
Hsu, David S. .
PLOS ONE, 2012, 7 (06)